Mechanisms of Ferroptosis and Relations With Regulated Cell Death: A Review.
Lei P, Bai T, Sun Y. · 2019
Read Mechanisms of Ferroptosis and Relations With Regulated Cell Death: A Review. by Lei P, Bai T, Sun Y. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6399426.txt.
Introduction
Lei and co-authors review ferroptosis in Frontiers in Physiology. Ferroptosis is a form of cell death driven by iron and by peroxides that build up in cell fats. It looks and acts unlike better known death forms.
Blocking a guard enzyme called GPX4 can trigger it. So can starving cells of cysteine, a building block for cell defenses. Rust-like iron chemistry sits at its core. The review splits its mechanisms into fat peroxide making and peroxide clearing. Ferroptosis matters for tumors, kidney failure, and organ injury, they note.
Catalog record
| CREATOR | Lei P, Bai T, Sun Y. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Mechanisms of Ferroptosis and Relations With Regulated Cell Death: A Review By Pengxu Lei, Tao Bai, Yuling Sun Published in: Frontiers in Physiology DOI: 10.3389/fphys.2019.00139 ABSTRACT Ferroptosis is a newly identified form of nonapoptotic regulated cell death (RCD) characterized by iron-dependent accumulation of lipid peroxides. It is morphologically and biochemically different from known types of cell death. Ferroptosis plays a vital role in the treatment of tumors, renal failure, and ischemia reperfusion injury (IRI). Inhibition of glutathione peroxidase 4 (GPX4), starvation of cysteine, and peroxidation of arachidonoyl (AA) trigger ferroptosis in the cells. Iron chelators, lipophilic antioxidants, and specific inhibitor prevent ferroptosis. Although massive researches have demonstrated the importance of ferroptosis in human, its mechanism is not really clear. In this review, we distanced ourselves from this confusion by dividing the mechanisms of ferroptosis into two aspects: processes that facilitate the formation of lipid peroxides and processes that suppress the reduction of lipid peroxides. At the same time, we summarize the relations between ferroptosis and several types of cell death. INTRODUCTION Cell death is the core of most pathological processes and is also an indispensable element of the regulation of normal tissues. Scientists originally thought that there were two forms of cell death: regulated cell death (RCD) and necrosis. Caspase-dependent apoptosis was widely considered to be synonymous with RCD, but the discovery of several types of nonapoptotic RCD revealed otherwise: apoptosis-inducing factor 1 (AIF1)-dependent parthanatos, receptor-interacting protein kinase 1 (RIPK1)-dependent necroptosis, and iron-dependent ferroptosis (Bergsbaken et al., 2009; Christofferson and Yuan, 2010; Dixon et al., 2012). Actually, before ferroptosis was named, this form of cell death had already been observed in vitro: two groups found that two small-molecule compounds, erastin and RAS-selective lethal 3 (RSL3), selectively killed oncogenic RAS mutant cells in vitro (Dolma et al., 2003; Yang and Stockwell, 2008). This form of cell death differed from known forms of cell death in morphological and biochemical features. Meanwhile, this process could be prevented by iron chelators and mediated by cellular iron abundance. This is why it was named ferroptosis (Dolma et al., 2003; Yagoda et al., 2007; Yang and Stockwell, 2008; Dixon et al., 2012). Since then, researchers have gradually uncovered the mechanism of ferroptosis, demonstrating that amino acids, lipids, and oxidation–reduction reaction are involved in this process (Dixon et al., 2012; Yang et al., 2014, 2016; Kagan et al., 2017). The iron-dependent accumulation of lipid peroxides is regarded as the lethal element. The decreased reduction of lipid peroxides caused by the inhibition of glutathione peroxidase 4 (GPX4) and the increased generation of lipid peroxides from arachidonoyl (AA) are two major pathways that lead to ferroptosis. Ferroptosis plays a vital role in human and participates in the initiation and development of numerous diseases [e.g., tumorigenesis, ischemia reperfusion injury (IRI), renal failure, nervous system diseases, and hematological system diseases] (Friedmann Angeli et al., 2014; Linkermann et al., 2014; Yang et al., 2014; Yu et al., 2015). Whether ferroptosis takes part in the development of more diseases is unclear, but it is believed that ferroptosis could be a physiological process that widely occurs in the body of mammals rather than a pathological or organ-specific process. Differed from other forms of cell death, ferroptosis shares a few common features with several other RCDs (Linkermann et al., 2014; Zille et al., 2017). MECHANISMS OF FERROPTOSIS Iron and lipid peroxides are two major participants in ferroptosis (Dixon et al., 2012; Yang et al., 2016; Kagan et al., 2017). It seems that the accumulation of lipid peroxides, mainly phosphatidylethanolamine-OOH (PE-OOH), ultimately results in ferroptosis (Kagan et al., 2017), while iron appears to serve as a catalyst or a component of a key regulator of ferroptosis (Toyokuni et al., 2017). Thus, iron chelators (e.g., deferoxamine) and several lipophilic antioxidants (e.g., α-tocopherol) can rescue ferroptosis (Yagoda et al., 2007; Yang and Stockwell, 2008; Zilka et al., 2017). Additionally, ROS produced through the Fenton reaction catalyzed by iron contributes to the initiation of ferroptosis (Toyokuni et al., 2017). ACCUMULATION OF LIPID PEROXIDES Under physiological condition, lipid peroxides (e.g., PE-OOH) are reduced to its corresponding lipid alcohols (e.g., PE-OH) by reductase to protect cells against oxidative stress (Brigelius-Flohe and Maiorino, 2013; Yang et al., 2014). Here, we roughly divide the processes that cause the accumulation of lipid peroxides into two aspects: processes that facilitate the formation of lipid peroxides and processes that inhibit the reduction of lipid peroxides. Processes That Inhibit the Reduction of Lipid Peroxides Toxic lipid peroxides are reduced to nontoxic lipid alcohols by GPX4 in the presence of glutathione (GSH), a cofactor of GPX4 (Brigelius-Flohe and Maiorino, 2013; Yang et al., 2014). GPX4 prevents cells against ferroptosis by eliminating intracellular lipid ROS and the inhibition of GPX4 triggers ferroptosis (Yang et al., 2014, 2016; Kinowaki et al., 2018). Containing eight nucleophilic amino acids (i.e., one selenocysteine and seven cysteines), GPX4 can react with electrophiles in the cell (Yang et al., 2016). Selenium is required for GPX4 to maintain its ferroptosis-resistance activity and replacing selenocysteine with cysteine sensitizes cells to ferroptosis (Friedmann Angeli and Conrad, 2018; Ingold et al., 2018). The inactivation or absence of GPX4 causes the accumulation of lipid peroxides, which is regarded as the lethal signal of ferroptotic cell death (Yang et al., 2016; Kagan et al., 2017). Thus, the inhibition of GPX4 is the critical step in ferroptosis. Several pathways are already known to lead to the inhibition of GPX4 and we review them here in association with their corresponding inducers, four small-molecule compounds (i.e., erastin, RSL3, FIN56, and FINO2) (Dolma et al., 2003; Yang and Stockwell, 2008; Shimada et al., 2016b; Gaschler et al., 2018a) (Table 1). [Table: Inducers that inhibit GPX4.] Erastin Erastin inhibits system xc_, a Na+-independent cystine/glutamate antiporter that can import a single molecule of cystine into the cells and export glutamic acid out of the cells in an ATP-dependent manner (Choi, 1988; Murphy et al., 1989; Dixon et al., 2012). System xc_ is a heterodimer composed of SLC7A11 and SLC3A2, linked by disulfide (Sato et al., 1999). How erastin inhibits system xc_ is unknown, but a change in SLC7A11 may be responsible for this inhibition (Dixon et al., 2012). The inhibition of system xc_ decreases the uptake of cystine, the oxidized form of cysteine. In cells, GSH synthase and glutamate cysteine synthase synthesize GSH with glutamate, glycine, and cysteine, which is reduced from cystine in the cell as substrates (Kagan et al., 2017). The decrease of cystine leads to the decrease of cysteine and the depletion of GSH. Serving as a cofactor of GPX4, GSH is required for the ferroptosis-resistance activity of GPX4. Inhibition of GPX4 suppresses the reduction of lipid peroxides to lipid alcohols, which leads to the accumulation of lipid peroxides. In addition, as one of the most abundant antioxidants, GSH functions to protect cells against ROS in the cell (Toyokuni et al., 2017). So, the depletion of GSH leads to the disequilibrium of antioxidant defense and the increase of lipid ROS. Thus, erastin induces ferroptosis by inhibiting the synthesis of GSH via decreasing the uptake of cysteine. The inhibition of GSH inactivates the GPX4 and reduces the oxidation resistance of the cell. These two processes lead to the accumulation of lipid peroxides and lipid ROS.